Overall Response

(N=71)*

1-year primary analysis1

  • 55% ORR (n=39; 95% CI: 43%, 67%)
    • 37% achieved a CR
    • 18% achieved a PR

3-year follow-up analysis2

  • 54% ORR (n=38; 95% CI: 41%, 66%)
    • 35% achieved a CR
    • 18% achieved a PR
View ORR

DURATION OF RESPONSE

(N=71)*

1-year primary analysis1

  • 21.7-month median DoR
    (range: 0, 24)

3-year follow-up analysis2

  • 43.9-month median DoR
    (95% CI: 15.0, NR)
Discover DoR

Accessibility

  • MONJUVI is administered in your office or clinic as a 1.5- to 2-hour infusion1
  • For the first infusion, use an infusion rate of 70 mL/h for the first 30 minutes, then, increase the rate so that the infusion is administered within 1.5 to 2.5 hours1